ライフサイエンスコーパス: inhalation anthrax

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 nfective dose of 10(4)B. anthracis cells for inhalation anthrax.

2 ely devoid of virulence, in a mouse model of inhalation anthrax.

3 ternative clinical treatment regimen against inhalation anthrax.

4 the incubation period distribution for human inhalation anthrax.

5 that accurately predict the effects of human inhalation anthrax.

6 effective emergency therapy of postexposure inhalation anthrax.

7 racis may be critical in the early stages of inhalation anthrax.

8 AD is highly attenuated in a mouse model for inhalation anthrax.

9 Inhalation anthrax, an often fatal infection, is initiat

10 lete solution for population protection from inhalation anthrax and has been associated with concerns

11 the onset of symptoms in all 6 survivors of inhalation anthrax and in 7 of 11 survivors of cutaneous

12 ients with bioterrorism-related cutaneous or inhalation anthrax and in a patient with laboratory-acqu

13 Since the initial events in inhalation anthrax are believed to be uptake of B. anthr

14 the protective activity of gammaDPGA Abs in inhalation anthrax are known.

15 During advanced stages of inhalation anthrax, Bacillus anthracis accumulates at hi

16 F detection as a tool for early diagnosis of inhalation anthrax before the onset of fulminant systemi

17 cells were detectable in all 6 survivors of inhalation anthrax but in only 2 of 7 patients with cuta

18 hylococcus aureus hematogenous pneumonia and inhalation anthrax but no activity against Streptococcus

19 We show that protection against inhalation anthrax by an irradiated spore vaccine depend

20 toxin may play a role in the pathogenesis of inhalation anthrax by facilitating the dissemination of

21 Systemic sepsis, most often associated with inhalation anthrax, can cause massive ascites, electroly

22 f-life confer significant protection against inhalation anthrax despite their lack of Fc regions.

23 otic that is used in combination therapy for inhalation anthrax disease.

24 LF, PA, and PGA levels during the course of inhalation anthrax in five rhesus macaques.

25 To better understand the pathogenesis of an inhalation anthrax infection, we propose a two-compartme

26 ategy for prophylaxis or treatment following inhalation anthrax infection.

27 Inhalation anthrax is a deadly disease for which there i

28 Successful postexposure treatment for inhalation anthrax is thought to include neutralization

29 xin genes and is capable of causing a severe inhalation anthrax-like illness.

30 conferred complete protection in the rabbit inhalation anthrax model.

31 us in the two most accepted animal models of inhalation anthrax, nonhuman primates and rabbits, but r

32 Prevention of inhalation anthrax requires early and extended antibioti

33 Inhalation anthrax results in high-grade bacteremia and

34 the site of entry for Bacillus anthracis in inhalation anthrax, the deadliest form of the disease.

35 spore-laced letters resulted in 22 cases of inhalation anthrax, with five fatalities.

36 emination and lethality in a murine model of inhalation anthrax, yet the roles for the toxins during

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。